Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com       Mergers, Acquisitions and Joint Ventures   Eli Lilly acquires CoLucid (Cambridge, MA, USA) and increases its migraine pain management with lasmiditan in a deal worth $960 million. Lasmiditan has completed the first of two pivotal phase 3 trials, a second one is expected […]

      1-Outsourced preparation of your next business convention: You would like to take part to next Bio Business convention (Bio-Europe Spring, Bio-Europe, BIO-US, BIO-Asia or other Business conventions). But a good preparation for a business convention is time-consuming and you have more important task to do. You can outsource the meeting requests to focus only on the last […]

    Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com     Editor’s Note   During a press conference on Wednesday, US President Elect Donald Trump promised to control drug prices in pledging aggressive federal bidding process. Some of the ex­cerpt: “We have to get our drug in­dus­try com­ing back. Our drug in­dus­try has been dis­as­trous. They […]

    Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com   Editor’s Note We wish all our subscribers and readers a Happy and Successful Year 2017 The year 2016 finished with an impressive scientific triumph that will change the way the medical community will fight the Ebola virus. An experimental Ebola vaccine named rVSV-ZEBOV, tested on humans in […]